View Older Stories View More Recent Stories

Nov 6, 2025 04:05PM Protagonist Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 28, 2025 09:26AM Protagonist Therapeutics (PTGX) PT Raised to $88 at Truist Securities
Oct 13, 2025 02:04PM Protagonist Therapeutics (PTGX) Said to Be Mentioned Cautiously Regarding M&A
Oct 13, 2025 05:04AM Protagonist Therapeutics (PTGX) PT Raised to $112 at BMO Capital
Oct 10, 2025 01:06PM Protagonist Therapeutics (PTGX) January 95 calls active, share price up 32%
Oct 10, 2025 11:27AM Protagonist Therapeutics stock surges after J&J acquisition talks report
Oct 10, 2025 11:16AM Protagonist Therapeutics (PTGX) halted on volatility
Oct 10, 2025 11:14AM Johnson & Johnson (JNJ) in talks to buy Protagonist Therapeutics (PTGX) - WSJ
Oct 8, 2025 09:08AM BMO Capital on Protagonist Therapeutics (PTGX): 'UEG Icotrokinra Full Data Remains Compelling'
Oct 7, 2025 11:00PM Jefferies says this stock offers favorable setup with further upside potential
Oct 7, 2025 02:50PM Protagonist Therapeutics (PTGX) PT Raised to $74 at Clear Street
Sep 17, 2025 04:35AM Barclays Starts Protagonist Therapeutics (PTGX) at Overweight
Sep 12, 2025 06:02AM Leerink Partners Starts Protagonist Therapeutics (PTGX) at Outperform
Aug 7, 2025 04:18AM Protagonist Therapeutics (PTGX) PT Raised to $69 at Citizens JMP
Aug 6, 2025 06:25PM Protagonist Therapeutics (PTGX) Tops Q2 EPS by 3c
Aug 6, 2025 04:05PM Protagonist Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Jul 1, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jun 17, 2025 05:19AM Citi Starts Protagonist Therapeutics (PTGX) at Buy
Jun 3, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jun 3, 2025 05:47AM Protagonist Therapeutics (PTGX) PT Lowered to $62 at Clear Street
Jun 3, 2025 05:16AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jun 2, 2025 10:29AM JPMorgan Reiterates Overweight Rating on Protagonist Therapeutics (PTGX)
May 6, 2025 04:05PM Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update
Apr 11, 2025 06:37AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Apr 11, 2025 05:15AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 11, 2025 09:02AM Protagonist Therapeutics (PTGX) PT Raised to $72 at BMO Capital Post ANTHEM/ICONIC Data
Mar 10, 2025 02:16PM Jefferies Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 10, 2025 09:34AM Protagonist Therapeutics (PTGX) PT Raised to $76 at Truist Securities
Mar 10, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 10, 2025 05:12AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 10, 2025 04:28AM Citizens JMP Reiterates Market Outperform Rating on Protagonist Therapeutics (PTGX)
Mar 4, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 3, 2025 02:34PM Protagonist Therapeutics (PTGX) PT Raised to $73 at BTIG
Mar 3, 2025 01:28PM Truist Securities Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 3, 2025 01:21PM TD Cowen Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Mar 3, 2025 11:52AM Protagonist Therapeutics (PTGX) PT Raised to $57 at JPMorgan
Mar 3, 2025 06:46AM Protagonist Therapeutics (PTGX) and Takeda (TAK) Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera
Feb 28, 2025 08:44AM JPMorgan Reiterates Overweight Rating on Protagonist Therapeutics (PTGX)
Feb 24, 2025 07:10AM Protagonist Therapeutics (PTGX) PT Raised to $54 at H.C. Wainwright
Feb 21, 2025 07:00AM Protagonist Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Feb 19, 2025 04:41AM Citizens JMP Reiterates Market Outperform Rating on Protagonist Therapeutics (PTGX)
Feb 7, 2025 09:47AM Truist Reiterates Buy Rating on Protagonist Therapeutics (PTGX) Following KOL Feedback
Feb 7, 2025 04:37AM JMP Securities Reiterates Market Outperform Rating on Protagonist Therapeutics (PTGX)
Jan 23, 2025 05:06AM Jefferies Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Jan 6, 2025 04:05PM Protagonist Therapeutics Reports Granting of Inducement Awards
Dec 12, 2024 01:16PM Clear Street Starts Protagonist Therapeutics (PTGX) at Buy, Top Pick
Dec 10, 2024 08:51AM BTIG Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Dec 5, 2024 04:10PM BMO Capital Starts Protagonist Therapeutics (PTGX) at Outperform
Nov 22, 2024 02:07PM Truist Securities Reiterates Buy Rating on Protagonist Therapeutics (PTGX)
Nov 22, 2024 05:21AM Protagonist Therapeutics (PTGX) PT Raised to $67 at BTIG
View More Recent Stories View Older Stories